Literature DB >> 17826414

Understanding the mechanism of learning enhancement: NMDA and GABA receptor expression.

Laura Toso1, Andrea Johnson, Stephanie Bissell, Robin Roberson, Daniel Abebe, Catherine Y Spong.   

Abstract

OBJECTIVE: The administration of neurotrophic peptides NAPVSIPQ (NAP) + SALLRSIPA (SAL) to aged mice resulted in significant learning enhancement. N-methyl-D-aspartate (NMDA) and gamma-aminobutyric acid (GABA) receptors are fundamental for learning because they are the major modulators of the long-term potentiation, the electrophysiologic mechanism for learning. Also, these receptors have been shown to be involved in NAP + SAL prevention of learning deficit in a mouse model for fetal alcohol syndrome, when administered prenatally during development. Our objective was to test whether NMDA and GABA receptors contribute to the learning enhancement that is induced by the peptides after adult administration. STUDY
DESIGN: Aged (14.5 months) male mice were treated for 10 consecutive days with placebo or D-NAP + D-SAL (20 microg, by gavage). At the end of the treatment, brains were harvested. Calibrator-normalized relative real-time polymerase chain reaction was performed with primers for GABA-(A)beta3, GABA-(A)alpha5, and the NMDA receptor subunits NR2A and NR2B, with GAPDH standardization. Statistical analysis included analysis of variance, with a probability value that was considered significant at <.05.
RESULTS: Five control brains and 6 brains from animals that were treated with NAP + SAL were collected. There was no difference in GABA-(A)beta3, GABA-(A)alpha5, NR2A, and NR2B subunits after adult administration of NAP + SAL, as compared with the controls (P > .05).
CONCLUSION: Postnatal treatment with NAP + SAL induced learning enhancement in aged mice with a mechanism that does not involve alteration in NMDA and GABA receptor expression. Thus, the mechanism of learning enhancement might be different for a developing fetus than an adult or in the absence of a perturbing agent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826414      PMCID: PMC2001299          DOI: 10.1016/j.ajog.2007.05.049

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  20 in total

1.  Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death.

Authors:  G W Glazner; A Boland; A E Dresse; D E Brenneman; I Gozes; M P Mattson
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

2.  Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome.

Authors:  Joy Vink; Jonathan Auth; Daniel T Abebe; Douglas E Brenneman; Catherine Y Spong
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

3.  Synergistic effects of the peptide fragment D-NAPVSIPQ on ethanol inhibition of synaptic plasticity and NMDA receptors in rat hippocampus.

Authors:  T A Zhang; A W Hendricson; M F Wilkemeyer; M J Lippmann; M E Charness; R A Morrisett
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 4.  Interneurons of the hippocampus.

Authors:  T F Freund; G Buzsáki
Journal:  Hippocampus       Date:  1996       Impact factor: 3.899

Review 5.  NMDA receptors: from genes to channels.

Authors:  N J Sucher; M Awobuluyi; Y B Choi; S A Lipton
Journal:  Trends Pharmacol Sci       Date:  1996-10       Impact factor: 14.819

6.  Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease.

Authors:  I Gozes; M Bachar; A Bardea; A Davidson; S Rubinraut; M Fridkin; E Giladi
Journal:  J Neurobiol       Date:  1997-09

Review 7.  An update on GABAA receptors.

Authors:  A K Mehta; M K Ticku
Journal:  Brain Res Brain Res Rev       Date:  1999-04

Review 8.  GABAergic cells and signals in CNS development.

Authors:  J L Barker; T Behar; Y X Li; Q Y Liu; W Ma; D Maric; I Maric; A E Schaffner; R Serafini; S V Smith; R Somogyi; J Y Vautrin; X L Wen; H Xian
Journal:  Perspect Dev Neurobiol       Date:  1998

9.  Prevention of alcohol-induced learning deficits in fetal alcohol syndrome mediated through NMDA and GABA receptors.

Authors:  Laura Toso; Sarah H Poggi; Robin Roberson; Jade Woodard; Jane Park; Daniel Abebe; Catherine Y Spong
Journal:  Am J Obstet Gynecol       Date:  2006-03       Impact factor: 8.661

10.  Neuroprotective peptides prevent some alcohol-induced alteration in gamma-aminobutyric acid A-beta3, which plays a role in cleft lip and palate and learning in fetal alcohol syndrome.

Authors:  Laura Toso; Robin Roberson; Daniel Abebe; Catherine Y Spong
Journal:  Am J Obstet Gynecol       Date:  2007-03       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.